CN120102879A - 检测胃肠道疾病的组合物和方法 - Google Patents

检测胃肠道疾病的组合物和方法 Download PDF

Info

Publication number
CN120102879A
CN120102879A CN202510261116.9A CN202510261116A CN120102879A CN 120102879 A CN120102879 A CN 120102879A CN 202510261116 A CN202510261116 A CN 202510261116A CN 120102879 A CN120102879 A CN 120102879A
Authority
CN
China
Prior art keywords
iap
nec
activity
protein
intestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202510261116.9A
Other languages
English (en)
Chinese (zh)
Inventor
金宣姈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Luis Anna State University Monitoring Committee College Of Agriculture And Mechanical Engineering
Original Assignee
Luis Anna State University Monitoring Committee College Of Agriculture And Mechanical Engineering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/267,120 external-priority patent/US11493515B2/en
Application filed by Luis Anna State University Monitoring Committee College Of Agriculture And Mechanical Engineering filed Critical Luis Anna State University Monitoring Committee College Of Agriculture And Mechanical Engineering
Publication of CN120102879A publication Critical patent/CN120102879A/zh
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/065Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
CN202510261116.9A 2019-02-04 2020-02-04 检测胃肠道疾病的组合物和方法 Pending CN120102879A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16/267,120 US11493515B2 (en) 2016-08-04 2019-02-04 Compositions and methods to detect gastrointestinal disease
US16/267,120 2019-02-04
CN202080027193.3A CN113645846B (zh) 2019-02-04 2020-02-04 检测胃肠道疾病的组合物和方法
PCT/US2020/016646 WO2020163381A1 (fr) 2019-02-04 2020-02-04 Compositions et procédés pour détecter une maladie gastro-intestinale

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202080027193.3A Division CN113645846B (zh) 2019-02-04 2020-02-04 检测胃肠道疾病的组合物和方法

Publications (1)

Publication Number Publication Date
CN120102879A true CN120102879A (zh) 2025-06-06

Family

ID=83366685

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202510261116.9A Pending CN120102879A (zh) 2019-02-04 2020-02-04 检测胃肠道疾病的组合物和方法
CN202080027193.3A Active CN113645846B (zh) 2019-02-04 2020-02-04 检测胃肠道疾病的组合物和方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202080027193.3A Active CN113645846B (zh) 2019-02-04 2020-02-04 检测胃肠道疾病的组合物和方法

Country Status (5)

Country Link
EP (1) EP3920713A4 (fr)
CN (2) CN120102879A (fr)
AU (1) AU2020217717B2 (fr)
CA (1) CA3128826A1 (fr)
WO (1) WO2020163381A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120673884A (zh) * 2025-08-20 2025-09-19 温州医科大学 基于ai的克林霉素磷酸酯加工水解优化方法及系统

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114113624B (zh) * 2020-08-28 2024-08-16 香港城市大学深圳研究院 利用免疫球蛋白关联蛋白质组开发疾病标志物的方法及装置
US11741686B2 (en) 2020-12-01 2023-08-29 Raytheon Company System and method for processing facility image data
WO2023141560A2 (fr) * 2022-01-20 2023-07-27 Synthetic Biologics, Inc. Phosphatase alcaline destinée à être utilisée en oncologie
CN116662798B (zh) * 2023-04-23 2026-02-24 迪辅乐生物(上海)有限公司 基于肠型分型的微生物组合物、过敏预测模型的构建方法及其模型和应用
WO2025075652A1 (fr) * 2023-10-06 2025-04-10 DeLorean Artificial Intelligence, Inc. Système et méthode de gestion de soins médicaux

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006026383A2 (fr) * 2004-08-26 2006-03-09 Strategic Health Decisions, Inc. Systeme pour optimiser les strategies de traitement au moyen d'un systeme d'evaluation specifique du patient
US20140162370A1 (en) * 2011-06-14 2014-06-12 The Board Of Trustees Of The Leland Stanford Junior University Urine biomarkers for necrotizing enterocolitis and sepsis
US10950353B2 (en) * 2013-09-20 2021-03-16 Georgia Tech Research Corporation Systems and methods for disease progression modeling
BR112017014419A2 (pt) * 2015-01-09 2018-01-16 S Malo Madhu diagnose e tratamento de diabetes incipiente
WO2018027179A1 (fr) * 2016-08-04 2018-02-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions et méthodes pour détecter une maladie gastro-intestinale
CN108061556B (zh) * 2017-10-18 2021-07-09 广州傲胜机器人科技有限公司 一种基于隐马尔可夫模型的地图匹配方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120673884A (zh) * 2025-08-20 2025-09-19 温州医科大学 基于ai的克林霉素磷酸酯加工水解优化方法及系统

Also Published As

Publication number Publication date
CN113645846B (zh) 2025-02-25
CN113645846A (zh) 2021-11-12
EP3920713A4 (fr) 2022-11-09
EP3920713A1 (fr) 2021-12-15
AU2020217717B2 (en) 2026-03-12
CA3128826A1 (fr) 2020-08-13
WO2020163381A1 (fr) 2020-08-13
AU2020217717A1 (en) 2021-09-30

Similar Documents

Publication Publication Date Title
CN113645846B (zh) 检测胃肠道疾病的组合物和方法
Chatzicostas et al. Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome
US11493515B2 (en) Compositions and methods to detect gastrointestinal disease
US8361732B2 (en) Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event
Lin et al. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients
Mori et al. Prognostic implications of the global leadership initiative on malnutrition criteria as a routine assessment modality for malnutrition in hospitalized patients at a university hospital
Yamout et al. Peritoneal and plasma D‐lactate concentrations in horses with colic
Dong et al. Hyperlipemia pancreatitis onset time affects the association between elevated serum triglyceride levels and disease severity
US9417247B2 (en) Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases
Patel et al. Clinical data do not reliably predict duodenal histology at follow-up in celiac disease: a 13 center correlative study
Benito et al. Lack of value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 for prediction of severe bacterial infections in infants with fever without a source
Sharif et al. Low serum albumin concentration predicts the need for surgical intervention in neonates with necrotizing enterocolitis
US11953501B2 (en) Compositions and methods to detect gastrointestinal disease
US20230258660A1 (en) A method for distinguishing healthy individuals from individuals having infectious or inflammatory conditions
Manzoor et al. Association of serum biochemical panel with mineralogical composition of kidney stone in India
US20240393333A1 (en) Compositions and methods to detect gastrointestinal disease
US12282019B2 (en) Compositions and methods to detect gastrointestinal disease
Dzudzor et al. Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design
EP3311164B1 (fr) Méthodes et compositions pour le diagnostic et le pronostic de l'appendicite et la différenciation des causes de la douleur abdominale
Firouzi et al. A cross-sectional study on the correlation between blood phosphorus level with sepsis and associated prognostic factors in neonates
Fawzy et al. Non-invasive follow-up of Egyptian patients infected with Helicobacter pylori by quantification of H. pylori circulating antigen in serum using ELISA
Yadav et al. Diagnostic Characteristics of Procalcitonin and Phospholipase A2 in Patients with Sepsis
Tramontano et al. Trend of C-Reactive protein after colorectal surgery may increase predictive value of anastomotic leak: a prospective analysis
Ming et al. U-shaped association between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol and risk of cholelithiasis: a cohort study
Jessee Stool studies: tried, true, and new

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination